Search This Blog

Thursday, March 10, 2022

Hoth Therapeutics Inc. (HOTH) Granted FDA Orphan Drug Designation

 for Treatment of Mastocytosis

https://www.streetinsider.com/Corporate+News/Hoth+Therapeutics+Inc.+%28HOTH%29+Granted+FDA+Orphan+Drug+Designation+for+Treatment+of+Mastocytosis/19758638.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.